Introduction
============

Endovascular treatment (EVT) for iliofemoral artery lesions has become common in the last decade due to technical developments related to self-expandable nitinol stents, and EVT is now an alternative first-line treatment with long-term outcomes that are not inferior to those after surgery.[@b1-mder-8-467],[@b2-mder-8-467] The high procedural success rate and reduced invasiveness has encouraged extension of indications for endovascular revascularization, but with little focus on hemodynamic significance. The current guidelines for peripheral artery disease indicate that EVT should be used with optimal drug treatment and supervised exercise therapy when clinical findings suggest a reasonable likelihood of symptomatic improvement. These guidelines also recommend pressure measurements across lesions at rest and under induced hyperemia in cases in which the hemodynamic significance of the target lesion is unclear.[@b3-mder-8-467],[@b4-mder-8-467] Various parameters have been proposed to determine hemodynamic significance, including mean pressure gradient (MPG), peak-to-peak PG, and ratio of mean pressure (also referred to as the peripheral fractional flow reserve \[pFFR\]) with or without vasodilators.[@b5-mder-8-467]--[@b9-mder-8-467] However, the validity of these parameters for treatment planning is unclear. Therefore, the purpose of this study was to verify whether trans-stenotic absolute PG and pFFR measured using a 0.014-inch pressure wire under hyperemia can be used to establish hemodynamic significance in iliofemoral angiographically intermediate stenosis.

Methods
=======

Study design and patient population
-----------------------------------

Pressure measurements were performed for 37 consecutive patients (40 lesions) with claudication and critical limb ischemia who had iliofemoral atherosclerotic artery disease for which EVT was planned according to comprehensive consideration of symptoms, quantitative vessel angiography results or duplex ultrasound (DUS) study in advance between April and August 2012 at Kokura Memorial Hospital. Patients who were planning to undergo EVT for TransAtlantic Inter-Society Consensus (TASC) II class C or D lesions, infrapopliteal artery lesions, chronic total occlusion, and surgical bypass grafts were excluded. Based on these criteria, the subjects were 22 patients (23 lesions) with intermediate stenosis, defined as \<75% stenosis on quantitative vessel angiography, identified retrospectively from our database. We did not defer the EVT from the results of pressure measurements. Kokura Memorial Hospital review board/ethics committee approved the study protocol. Written informed consent was obtained from each patient.

Pressure measurements
---------------------

Pressure measurements were performed using a 0.014-inch pressure wire (300 cm PrimeWire Prestage^®^; Volcano Corporation, San Diego, CA, USA) following angiography and just before starting EVT. The pressure wire was calibrated before the procedure, equalized at the end of the guiding system, advanced over the lesion, and positioned in a distal healthy area. The mean trans-stenotic absolute PG (baseline MPG) and mean pressure ratio (baseline MPR) were then measured. Next, 250 µg of isosorbide dinitrate (ISDN) was injected via the guiding system to induce a hyperemic state. Hyperemic MPG and MPR were then measured, usually approximately 1 minute after flushing the guiding system with saline. MPG was defined as the difference between the mean pressure in the distal healthy area across the lesion from the pressure wire (mean distal pressure) and the mean central aorta pressure from the guiding system (mean aorta pressure). MPR was calculated as mean distal pressure/mean aorta pressure. Hyperemic MPR was considered equivalent to pFFR.

DUS study
---------

The peak systolic velocity ratio (PSVR) on duplex (DUS) was used to define the hemodynamic severity of lesions. Tests were performed by certified sonographers within 30 days before pressure measurements. PSVR was calculated by dividing the velocity measured at the point of maximum stenosis by the velocity in the closest adjacent healthy vessel segment.

Outcomes
--------

Comparisons of baseline MPG to hyperemic MPG, and baseline MPR to hyperemic MPR (pFFR) were performed to assess responses of these parameters to vasodilators. Correlations of PSVR on DUS with hyperemic MPG and pFFR were examined. Optimal cut-off values were determined for hyperemic MPG and pFFR as indicators of hemodynamically significant stenosis (PSVR \>2.5 on DUS).

Statistical analysis
--------------------

Continuous variables are presented as means with standard deviation and categorical variables as numbers with percentages. Continuous variables were compared by Student's *t*-test and correlations between continuous variables were examined using simple linear regression. A receiver operating characteristic analysis was used to determine the optimal cut-off values for hyperemic MPG and pFFR. *P*\<0.05 was regarded as significant. All analyses were performed using JMP^®^ version 10.0 (SAS Institute Inc., Cary, NC, USA).

Results
=======

The characteristics of the patients are shown in [Table 1](#t1-mder-8-467){ref-type="table"} and the characteristics of lesions are shown in [Table 2](#t2-mder-8-467){ref-type="table"}. The patients had a mean age of 72.2±6.8 years (range: 61--86 years) and 19 were male. Almost half of the patients had coronary artery disease (CAD) and three were receiving hemodialysis. All patients had intermittent claudication, except for four with critical limb ischemia. The mean % stenosis diameter was 57.3%±13.2%, and 91% of the lesions were classified as TASC II A.

MPG increased significantly after injection of ISDN (from 9.0±5.7 to 16.3±6.2 mmHg; *P*\<0.05, [Figure 1](#f1-mder-8-467){ref-type="fig"}). Baseline MPG was not significantly correlated with PSVR (*R*=0.33; *P*=0.12); however, hyperemic MPG was significantly correlated with PSVR (*R*=0.52; *P*\<0.05, [Figure 2](#f2-mder-8-467){ref-type="fig"}).

MPR decreased significantly after injection of ISDN (from 0.92±0.06 to 0.81±0.07; *P*\<0.05, [Figure 3](#f3-mder-8-467){ref-type="fig"}). Baseline MPR was not significantly correlated with PSVR (*R*=−0.32; *P*=0.16); however, hyperemic MPR (pFFR) was significantly correlated with PSVR (R=−0.50; *P*\<0.05, [Figure 4](#f4-mder-8-467){ref-type="fig"}).

The optimal cut-off value for pFFR for hemodynamically significant stenosis (defined as PSVR \>2.5) was 0.85 (area under the curve \[AUC\] 0.72; sensitivity 94%; specificity 50%, *P*\<0.05, [Figure 5](#f5-mder-8-467){ref-type="fig"}). Hyperemic MPG was not a significant predictor of hemodynamically significant stenosis (AUC 0.48; sensitivity 71%; specificity: 87%, *P*=0.95).

Discussion
==========

The major findings in this study of iliofemoral angiographically intermediate stenosis were that hemodynamic significance can be established more accurately under hyperemia induced by ISDN, compared to a resting state; that hyperemic MPG and hyperemic MPR (pFFR) are both significantly correlated with PSVR on DUS; and that the optimal cut-off value for pFFR as an indicator of hemodynamic significance (PSVR \>2.5) was 0.85.

In CAD, common physiological findings are included in planning a revascularization strategy for non-severe stenosis. We routinely employ stress tests for coronary blood flow through exercise or pharmacologic stimulation, and coronary pressure measurements are commonly used for assessment of the ischemic potential of a stenosis in our daily practice. Recent large clinical trials have established fractional flow reserve (FFR) measured using a pressure wire as a standard diagnostic tool in patients with non-severe stenosis.[@b10-mder-8-467],[@b11-mder-8-467] In peripheral artery disease, hyperemic translesional MPG and renal FFR are important as physiological parameters in endovascular revascularization for renal artery stenosis (RAS). Current American College of Cardiology/American Heart Association guidelines recommend pressure measurements for understanding the functional significance in RAS.[@b12-mder-8-467],[@b13-mder-8-467]

Unlike in CAD or RAS, pressure measurements are not commonly used for iliofemoral disease with intermediate stenosis although there might be high frequencies of visual-functional mismatch between moderate morphologic stenosis (\>50% in angiography) and pressure ratio.[@b14-mder-8-467] A residual MPG \<10 mmHg after intervention has been suggested as an indicator of hemodynamic significance in iliac arteries.[@b4-mder-8-467] However, this criterion is based on findings obtained using 5 Fr catheters, and large diameter catheters always overestimate the PG compared with a pressure wire.[@b5-mder-8-467] In addition, there are no data on the clinical value of using vasodilators and pFFR measurements for iliofemoral disease with intermediate stenosis. In contrast, DUS is frequently used for planning of iliofemoral artery revascularization (both endovascular and surgical) in daily practice. The quality of this examination depends on the experience of sonographers and data interpretation can be time-consuming; but the method is noninvasive, and provides information on lesion locations and stenosis in two dimensions, and on hemodynamic severity based on PSVR.[@b15-mder-8-467],[@b16-mder-8-467]

The results of the current study revealed the importance of inducing a hyperemic state in evaluation of iliofemoral artery circulation. The findings support our hypothesis that pressure measurements for iliofemoral angiographic mild to moderate stenosis can be used in place of DUS to evaluate hemodynamic significance. Thus, measurement of hyperemic MPG and pFFR using a pressure wire can be used to assess the hemodynamic severity of a lesion (which was not evaluated in DUS before EVT) in a catheter laboratory and to perform intervention with the pressure wire across the lesion based on pFFR reaching the threshold described above. We note that modern pressure wires have improved durability and torque, and thus EVT using a pressure wire is not stressful for operators, except for treating complex lesions such as those in the TASC II C/D class. Hyperemic MPG also had a significant correlation with PSVR on DUS, but we were unable to establish a threshold MPG as an indicator of hemodynamic significance in the current study. This parameter is an absolute value that depends strongly on blood pressure. Therefore, there is likely to be a wide range of hyperemic MPG values in iliofemoral arteries that may or may not reflect hemodynamic significance ([Figure 2](#f2-mder-8-467){ref-type="fig"}). Thus, we conclude that hyperemic MPR (pFFR) is a better measure of hemodynamic significance.

Limitations
===========

There were several limitations in the study. First, the study population was identified retrospectively and the sample size was small. Second, correlations between hyperemic pressure measurements and PSVR on DUS were significant, but only moderate. Third, some cases had diffuse long lesions (especially for superficial femoral lesions); thus, some of the lesions on which pressure measurements were performed in our catheter laboratory did not strictly correspond to the positions of lesions evaluated on DUS by sonography in the vascular laboratory. This inadequate correspondence might be one of the reasons behind the poor specificity in pFFR measurement (only 50%) in the present study. Finally, a dose of 250 µg of ISDN was used to induce hyperemia, but a different dose of ISDN or another vasodilator (nitroglycerine, papaverine, adenosine) may alter the results.[@b17-mder-8-467] In the future, a validation study examining the type and dose of vasodilator would be needed.

Conclusion
==========

Induction of a hyperemic state is required for pressure measurements in iliofemoral artery circulation. Hyperemic MPR (pFFR) measured using a 0.014-inch pressure wire is reliable for prediction of hemodynamic significance in iliofemoral angiographically mild to moderate stenosis. The optimal cut-off value of pFFR for hemodynamic significance was 0.85.
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![Changes in MPG measured by PW from baseline to hyperemia.\
**Note:** MPG increased significantly after injection of ISDN (from 9.0±5.7 to 16.3±6.2 mmHg; *P*\<0.05).\
**Abbreviations:** MPG, mean pressure gradient; ISDN, isosorbide dinitrate; PW, pressure wire.](mder-8-467Fig1){#f1-mder-8-467}

![Relationship of hyperemic MPG with PSVR.\
**Note:** Hyperemic MPG was significantly correlated with PSVR (*R*=0.52; *P*\<0.05).\
**Abbreviations:** MPG, mean pressure gradient; PSVR, peak systolic velocity ratio.](mder-8-467Fig2){#f2-mder-8-467}

![Changes in MPR from baseline to hyperemia.\
**Note:** MPR decreased significantly after injection of ISDN (from 0.92±0.06 to 0.81±0.07; *P*\<0.05)\
**Abbreviations:** MPG, mean pressure gradient; ISDN, isosorbide dinitrate; PW, pressure wire.](mder-8-467Fig3){#f3-mder-8-467}

![Relationship of hyperemic mean pressure ratio (MPR) with peak systolic velocity ratio (PSVR).\
**Note:** Hyperemic MPR (pFFR) was significantly correlated with PSVR (*R*=−0.50; *P*\<0.05).\
**Abbreviations:** MPG, mean pressure gradient; PSVR, peak systolic velocity ratio; pFFR, peripheral fractional flow reserve.](mder-8-467Fig4){#f4-mder-8-467}

![Receiver operating characteristic curve of hyperemic mean pressure ratio (MPR) for prediction of hemodynamically significant stenosis (peak systolic velocity ratio \>2.4).\
**Notes:** The optimal cut-off for hyperemic MPR (peripheral fractional flow reserve) was 0.85 (AUC 0.72; sensitivity 94%; specificity 50%, *P*\<0.05).\
**Abbreviations:** MPG, mean pressure gradient; AUC, area under the curve.](mder-8-467Fig5){#f5-mder-8-467}

###### 

Patient characteristics for pressure measurements (N=22)

                              Mean ± SD or Number (%)
  --------------------------- -------------------------
  Age, years                  72.2±6.8
  Sex, male                   19 (86)
  Left lower extremity        14 (64)
  Hypertension                19 (86)
  Dyslipidemia                13 (59)
  Diabetes mellitus           14 (64)
  Current smoking             6 (27)
  Previously smoked           12 (55)
  Coronary artery disease     13 (59)
  Ejection fraction (%)       59±13
  Cerebrovascular disease     6 (27)
  Hemodialysis                3 (14)
  Rutherford classification   
   0                          1 (5)
   1                          1 (5)
   2                          6 (27)
   3                          11 (50)
   4                          3 (14)
   5                          1 (5)
   6                          0

**Abbreviation:** SD, standard deviation.

###### 

Lesion characteristics (N=23)

                                   Mean ± SD or Number (%)
  -------------------------------- -------------------------
  Minimum lesion length (mm)       2.1±1.3
  Reference vessel diameter (mm)   5.2±2.9
  Diameter stenosis (%)            57.3±13.2
  Lesion length (mm)               32.0±19.0
  Lesion location                  
   Iliac                           8 (35)
   Femoropopliteal                 15 (65)
  Restenosis                       8 (35)
  Below the knee runoff            
   0/3                             0
   1/3                             6 (26)
   2/3                             7 (10)
   3/3                             10 (43)
  TASC II classification           
   A                               21 (91)
   B                               2 (9)

**Abbreviations:** SD, standard deviation; TASC, TransAtlantic Inter-Society Consensus.
